These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 27235133)

  • 1. New drug treatments versus structured education programmes for type 2 diabetes: comparing cost-effectiveness.
    Khunti K; Chatterjee S; Carey M; Daly H; Batista-Ferrer H; Davies MJ
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):557-9. PubMed ID: 27235133
    [No Abstract]   [Full Text] [Related]  

  • 2. The cost-effectiveness analysis of JinQi Jiangtang tablets for the treatment on prediabetes: a randomized, double-blind, placebo-controlled, multicenter design.
    Sun X; Guo L; Shang H; Ren M; Wang Y; Huo D; Lei X; Wang H; Zhai J
    Trials; 2015 Nov; 16():496. PubMed ID: 26530718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes education. An idea whose time has come.
    Hanley R
    N C Med J; 1992 May; 53(5):238-40. PubMed ID: 1625758
    [No Abstract]   [Full Text] [Related]  

  • 4. [Assessment of novel antidiabetic drugs in Germany. Do innovations still have a chance?].
    Gallwitz B
    MMW Fortschr Med; 2014 Jul; 156(13):57-60. PubMed ID: 25318228
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-effectiveness of a diabetes group education program delivered by health promoters with a guiding style in underserved communities in Cape Town, South Africa.
    Mash R; Kroukamp R; Gaziano T; Levitt N
    Patient Educ Couns; 2015 May; 98(5):622-6. PubMed ID: 25641665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating the short-term cost-effectiveness of liraglutide versus sitagliptin in patients with type 2 diabetes failing metformin monotherapy in the United States.
    Langer J; Hunt B; Valentine WJ
    J Manag Care Pharm; 2013 Apr; 19(3):237-46. PubMed ID: 23537458
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of type 2 diabetes mellitus: proven and new aspects].
    Ritzel RA; Isermann B; Woerle HJ
    Dtsch Med Wochenschr; 2007 May; 132(19):1057-61. PubMed ID: 17476638
    [No Abstract]   [Full Text] [Related]  

  • 8. Cost-Effectiveness of Individualized Management of Diabetes Among U.S. Adults.
    Ann Intern Med; 2018 Feb; 168(3):. PubMed ID: 29230474
    [No Abstract]   [Full Text] [Related]  

  • 9. How can structured self-management patient education improve outcomes in people with type 2 diabetes?
    Jarvis J; Skinner TC; Carey ME; Davies MJ
    Diabetes Obes Metab; 2010 Jan; 12(1):12-9. PubMed ID: 19788430
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HypoAware-a brief and partly web-based psycho-educational group intervention for adults with type 1 and insulin-treated type 2 diabetes and problematic hypoglycaemia: design of a cost-effectiveness randomised controlled trial.
    Rondags SM; de Wit M; van Tulder MW; Diamant M; Snoek FJ
    BMC Endocr Disord; 2015 Aug; 15():43. PubMed ID: 26292674
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Economics of type 2 diabetes prevention.
    Kissimova-Skarbek K
    Przegl Lek; 2006; 63 Suppl 4():9-11. PubMed ID: 16967708
    [No Abstract]   [Full Text] [Related]  

  • 12. Self management of diabetes. Fallacy in intervention model.
    Yudkin JS
    BMJ; 2010 Oct; 341():c5818. PubMed ID: 20959301
    [No Abstract]   [Full Text] [Related]  

  • 13. Costs and effects of a telephonic diabetes self-management support intervention using health educators.
    Schechter CB; Walker EA; Ortega FM; Chamany S; Silver LD
    J Diabetes Complications; 2016 Mar; 30(2):300-5. PubMed ID: 26750743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic review on the cost-effectiveness of self-management education programme for type 2 diabetes mellitus.
    Lian JX; McGhee SM; Chau J; Wong CKH; Lam CLK; Wong WCW
    Diabetes Res Clin Pract; 2017 May; 127():21-34. PubMed ID: 28315575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes research in health care: simulations to drive cost conclusions.
    Frear R; Motheral B
    Value Health; 2004; 7(1):11-2. PubMed ID: 14720126
    [No Abstract]   [Full Text] [Related]  

  • 16. Economic models in type 2 diabetes.
    Yi Y; Philips Z; Bergman G; Burslem K
    Curr Med Res Opin; 2010 Sep; 26(9):2105-18. PubMed ID: 20642392
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost analysis of group versus usual care in patients with type 2 diabetes in the ROMEO clinical trial.
    Sicuro J; Bondonio P; Charrier L; Berchialla P; Cavallo F; Porta M; Trento M
    Nutr Metab Cardiovasc Dis; 2013 Feb; 23(2):e13-4. PubMed ID: 23220076
    [No Abstract]   [Full Text] [Related]  

  • 18. The ACHRU-CPP versus usual care for older adults with type-2 diabetes and multiple chronic conditions and their family caregivers: study protocol for a randomized controlled trial.
    Markle-Reid M; Ploeg J; Fraser KD; Fisher KA; Akhtar-Danesh N; Bartholomew A; Gafni A; Gruneir A; Hirst SP; Kaasalainen S; Stradiotto CK; Miklavcic J; Rojas-Fernandez C; Sadowski CA; Thabane L; Triscott JA; Upshur R
    Trials; 2017 Feb; 18(1):55. PubMed ID: 28166816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Estimating the direct cost of Type 2 diabetes in Greece: the effects of blood glucose regulation on patient cost.
    Athanasakis K; Ollandezos M; Angeli A; Gregoriou A; Geitona M; Kyriopoulos J
    Diabet Med; 2010 Jun; 27(6):679-84. PubMed ID: 20546287
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of diabetes self-management programs in community primary care settings.
    Brownson CA; Hoerger TJ; Fisher EB; Kilpatrick KE
    Diabetes Educ; 2009; 35(5):761-9. PubMed ID: 19622716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.